SPARK System
Gait impairment due to Stroke, Cerebral Palsy, and other neurological conditions
Pilot/TestingActive
Key Facts
Indication
Gait impairment due to Stroke, Cerebral Palsy, and other neurological conditions
Phase
Pilot/Testing
Status
Active
Company
About Biomotum
Biomotum is a private, pre-revenue medical device startup founded in 2019 and based in Cambridge, USA. The company is developing the SPARK, an on-demand robotic exoskeleton system for gait rehabilitation in clinical settings, targeting patients with stroke, cerebral palsy, and other neurological conditions. With a planned international launch in early 2026, Biomotum is currently engaging select clinics as pilot partners to evaluate its technology. The company is led by a team of engineers and entrepreneurs and is advised by experts in medical device development, regulatory strategy, and commercialization.
View full company profile